Two Sigma Securities’s Lunai Bioworks LNAI Stock Holding History

Two Sigma Securities’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,137	Closed	-$10.2K	–	2253
2026 Q1	$10.2K	Buy	+3,137	New	+$15.6K	﹤0.01%	1462
2025 Q3	–	Sell	-162	Closed	-$3.75K	–	1900
2025 Q2	$3.75K	Buy	+162	New	+$4.52K	﹤0.01%	1375
2025 Q1	–	Sell	-211	Closed	-$14.1K	–	2073
2024 Q4	$14.1K	Buy	+211	New	+$14K	﹤0.01%	1379
2024 Q3	–	Sell	-210	Closed	-$29.4K	–	3496
2024 Q2	$29.4K	Buy	+210	New	+$28.6K	﹤0.01%	2642

Other funds holding LNAI

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Two Sigma Securities's LNAI Position: Q2 2026 in Review

Two Sigma Securities sold out of Lunai Bioworks (LNAI) in Q2 2026, closing a stake of 3,137 shares — an estimated $10.2K sold.

Two Sigma Securities first reported a position in LNAI in Q2 2024 and held it in 4 quarters. The position peaked at $29.4K in Q2 2024. 15 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

Two Sigma Securities reported no remaining Lunai Bioworks position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 3,137 Lunai Bioworks shares in Q2 2026, an estimated $10.2K.
Two Sigma Securities first reported a position in Lunai Bioworks in Q2 2024 and held it in 4 quarters.
Two Sigma Securities's Lunai Bioworks position peaked at $29.4K in Q2 2024.
15 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.